THW / Abrdn World Healthcare Fund - Документы SEC, Годовой отчет, Доверенное заявление

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant     ☒ Filed by a Party other than the Registrant      ☐ Check the appropriate box: ☐        Preliminary Proxy Statement ☐        Confidential, for Use of the Commission

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant     ☒ Filed by a Party other than the Registrant      ☐ Check the appropriate box: ☐        Preliminary Proxy Statement ☐        Confidential, for Use of the Commission

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. __)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. __)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. __)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. __)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin

BY-LAWS TEKLA WORLD HEALTHCARE FUND Revised through June 8, 2023 ARTICLE I

Exhibit (b) BY-LAWS OF TEKLA WORLD HEALTHCARE FUND Revised through June 8, 2023 ARTICLE I Definitions The terms “Commission,” “Custodian,” “Declaration,” “Distributor,” “Investment Adviser,” “Majority Shareholder Vote,” “1940 Act,” “Shareholder,” “Shares,” “Transfer Agent,” “Trust,” “Trust Property” and “Trustees” have the respective meanings given them in the Declaration of Trust of Tekla World Healthcare Fund dated March 5, 2015, as amended from time to time.

As filed with the Securities and Exchange Commission on September 27, 2023 1933 Act File No. 333-267555 1940 Act File No. 811-23037 SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM N-2            REGISTRATION STATEMENT UNDER THE SECURITIE

As filed with the Securities and Exchange Commission on September 27, 2023 1933 Act File No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. __)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. __)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. __)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 12, 2023 (September 6, 2023) Tekla World Healthcare Fund (Exact name of Registrant as Specified in Its Charter) Massachusetts 811-23037 47-3910842 (State or other jurisdicti

September 12, 2023 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549-7561 Dear Sirs/Madams: We have read Item 4.01 of Tekla World Healthcare Fund's Form 8-K dated September 12, 2023, and we agree with the statements made th

Exhibit 16.1 September 12, 2023 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549-7561 Dear Sirs/Madams: We have read Item 4.01 of Tekla World Healthcare Fund's Form 8-K dated September 12, 2023, and we agree with the statements made therein. Yours truly, Deloitte & Touche LLP 200 Berkeley Street Boston, MA 02116 USA Tel: 617-437-2625 Fax: 617-437-4625 www.deloitte.com

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. __)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. __)

DEFA14A 1 tm2325074d1defa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (

Tekla Healthcare Investors Tekla Life Sciences Investors Tekla Healthcare Opportunities Fund Tekla World Healthcare Fund

Tekla Healthcare Investors Tekla Life Sciences Investors Tekla Healthcare Opportunities Fund Tekla World Healthcare Fund August 22, 2023 Via EDGAR Mindy Rotter U.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. __)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. __)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. __)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. __)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. __)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. __)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. __)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. __)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: x Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 19, 2022 (December 14, 2022) Tekla World Healthcare Fund (Exact name of Registrant as Specified in Its Charter) Massachusetts 811-23037 47-3910842 (State or other jurisdictio

SUB-PLACEMENT AGENT AGREEMENT Foreside Fund Services, LLC Three Canal Plaza, Suite 100 Portland, Maine 04101

Exhibit 1.2 SUB-PLACEMENT AGENT AGREEMENT Foreside Fund Services, LLC Three Canal Plaza, Suite 100 Portland, Maine 04101 December 14, 2022 UBS Securities LLC 1285 Avenue of the Americas New York, New York 10019 RE: At-the-Market Offerings by Tekla World Healthcare Fund Ladies and Gentlemen: From time to time Foreside Fund Services, LLC (the ?Distributor,? ?we? or ?us?) will act as manager of regis

DISTRIBUTION AGREEMENT

EX-1.1 2 tm2232946d1ex1-1.htm EXHIBIT 1.1 Exhibit 1.1 DISTRIBUTION AGREEMENT This DISTRIBUTION AGREEMENT (this “Agreement”) made as of December 14, 2022 by and between Tekla World Healthcare Fund, a Massachusetts business trust (the “Fund”), and Foreside Fund Services, LLC, a Delaware limited liability company (the “Distributor”). WITNESSETH: WHEREAS, the Fund is registered under the Investment Co

TEKLA WORLD HEALTHCARE FUND Common Shares of Beneficial Interests Having an Aggregate Initial Offering Price of Up to $150,000,000

Filed Pursuant to Rule 424(b)(5) Securities Act File No. 333-267555 Investment Company Act File No. 811-23037 PROSPECTUS SUPPLEMENT (to Prospectus dated December 6, 2022) TEKLA WORLD HEALTHCARE FUND Common Shares of Beneficial Interests Having an Aggregate Initial Offering Price of Up to $150,000,000 Tekla World Healthcare Fund (the “Trust”) is a non-diversified, closed-end management investment c

TRUST EXPENSES

CORRESP 1 filename1.htm 1095 Avenue of the Americas New York, NY 10036-6797 +1 212 698 3500 Main +1 212 698 3599 Fax www.dechert.com Allison M. Fumai [email protected] +1 212 698 3526 Direct +1 212 698 3599 Fax November 29, 2022 VIA EDGAR Ms. Mindy Rotter Division of Investment Management Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Re: Tekla World Healthcare

*             *             *

CORRESP 1 filename1.htm 1095 Avenue of the Americas New York, NY 10036-6797 +1 212 698 3500 Main +1 212 698 3599 Fax www.dechert.com Allison M. Fumai [email protected] +1 212 698 3526 Direct +1 212 698 3599 Fax November 10, 2022 VIA EDGAR Mses. Mindy Rotter and Karen Rossotto Division of Investment Management Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Re: Te

As filed with the Securities and Exchange Commission on Jul 29, 2022

POS EX 1 tm2221745d4posex.htm POS EX As filed with the Securities and Exchange Commission on Jul 29, 2022 Securities Act File No. 333-251975 Investment Company Act File No. 811-23037 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM N-2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 x Pre-Effective Amendment No. Post-Effective Amendment No. 4 REGISTRATION STATEM

TEKLA WORLD HEALTHCARE FUND Amendment to Declaration of Trust Notice of Change of Trustee

Exhibit (a)(ix) TEKLA WORLD HEALTHCARE FUND Amendment to Declaration of Trust Notice of Change of Trustee WHEREAS, upon the death of Oleg M.

Notice of Change of Trustee, filed herewith

Exhibit (a)(viii) TEKLA WORLD HEALTHCARE FUND Amendment to Declaration of Trust Notice of Change of Trustee WHEREAS, at a meeting of the shareholders of Tekla World Healthcare Fund (the ?Fund?), the shareholders of the Fund appointed W.

Power of Attorney dated June 9, 2022, filed herewith

EX-99.(N)(II) 3 tm2219130d4ex99-nii.htm EXHIBIT 99.(N)(II) Exhibit (n)(ii) POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that W. Mark Watson, whose signature appears below, constitutes and appoints Daniel R. Omstead, Laura Woodward, Christopher Harvey and Kaitlin McGrath and each of them, his or her true and lawful attorney-in-fact and agent, with full power of substitution among himself o

As filed with the Securities and Exchange Commission on July 1, 2022

As filed with the Securities and Exchange Commission on July 1, 2022 Securities Act File No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin

Tekla World Healthcare Fund SCHEDULE OF INVESTMENTS December 31, 2021

Tekla World Healthcare Fund SCHEDULE OF INVESTMENTS December 31, 2021 (Unaudited) PRINCIPAL AMOUNT NON-CONVERTIBLE NOTES - 11.

Notice of Change of Trustee, dated December 22, 2021

Exhibit (a)(vii) TEKLA WORLD HEALTHCARE FUND Amendment to Declaration of Trust Notice of Change of Trustee WHEREAS, by Action of Written Consent, the Trustees of Tekla World Healthcare Fund (?The Fund?), the Trustees of the Fund appointed Kathleen L.

Powers of Attorney dated November 30, 2021, filed herewith

Exhibit (n)(ii) POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that Kathleen L.

As filed with the Securities and Exchange Commission on December 22, 2021

POS EX 1 tm2134557d4posex.htm POS EX As filed with the Securities and Exchange Commission on December 22, 2021 Securities Act File No. 333-251975 Investment Company Act File No. 811-23037 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM N-2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 x Pre-Effective Amendment No. Post-Effective Amendment No. 2 REGISTRATION S

Tekla World Healthcare Fund SCHEDULE OF INVESTMENTS June 30, 2021

Tekla World Healthcare Fund SCHEDULE OF INVESTMENTS June 30, 2021 (Unaudited) PRINCIPAL AMOUNT VALUE NON-CONVERTIBLE NOTES - 13.

As filed with the Securities and Exchange Commission on July 2, 2021

As filed with the Securities and Exchange Commission on July 2, 2021 Securities Act File No.

Notice of Change of Trustee dated June 16, 2021

Exhibit (a)(vi) TEKLA WORLD HEALTHCARE FUND Amendment to Declaration of Trust Notice of Change of Trustee WHEREAS, Lucinda H.

- DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin

TEKLA WORLD HEALTHCARE FUND 10,077,635 Shares Issuable Upon Exercise Of Non-Transferable Rights To Subscribe For Such Shares New York Stock Exchange Symbol: THW

File No. 333-251975 Rule 424(b)(1) PROSPECTUS TEKLA WORLD HEALTHCARE FUND 10,077,635 Shares Issuable Upon Exercise Of Non-Transferable Rights To Subscribe For Such Shares New York Stock Exchange Symbol: THW Tekla World Healthcare Fund (the "Trust") is issuing non-transferable rights ("Rights") to its Shareholders of record as of the close of business on March 8, 2021 (the "Record Date"). These Rig

Tekla World Healthcare Fund SCHEDULE OF INVESTMENTS DECEMBER 31, 2020

Tekla World Healthcare Fund SCHEDULE OF INVESTMENTS DECEMBER 31, 2020 (Unaudited) PRINCIPAL AMOUNT VALUE CONVERTIBLE AND NON-CONVERTIBLE NOTES - 18.

* * *

1095 Avenue of the Americas New York, NY 10036-6797 +1 212 698 3500 Main +1 212 698 3599 Fax www.

By-Laws of the Registrant, as amended(9)

Exhibit (b) BY-LAWS OF TEKLA WORLD HEALTHCARE FUND Revised through December 10, 2020 ARTICLE I Definitions The terms “Commission,” “Custodian,” “Declaration,” “Distributor,” “Investment Adviser,” “Majority Shareholder Vote,” “1940 Act,” “Shareholder,” “Shares,” “Transfer Agent,” “Trust,” “Trust Property” and “Trustees” have the respective meanings given them in the Declaration of Trust of Tekla World Healthcare Fund dated March 5, 2015, as amended from time to time.

- POS EX

As filed with the Securities and Exchange Commission on January 5, 2020 Securities Act File No.

Notice of Change of Trustee dated August 27, 2020

Exhibit (a)(v) TEKLA WORLD HEALTHCARE FUND Amendment to Declaration of Trust Notice of Change of Trustee WHEREAS, by Action of Written Consent, the Trustees of Tekla World Healthcare Fund (“The Fund”), the Trustees of the Fund appointed Jeffrey A.

Power of attorney dated August 27, 2020(8)

Exhibit (n)(ii) POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that Jeffrey A.

- POS EX

As filed with the Securities and Exchange Commission on September 10, 2020 Securities Act File No.

Tekla World Healthcare Fund SCHEDULE OF INVESTMENTS June 30, 2020 (Unaudited, continued)

Tekla World Healthcare Fund SCHEDULE OF INVESTMENTS June 30, 2020 (Unaudited, continued) PRINCIPAL AMOUNT VALUE CONVERTIBLE AND NON-CONVERTIBLE NOTES - 19.

-

Tekla Healthcare Investors Tekla Life Sciences Investors 100 Federal Street, 19th Floor Tekla Healthcare Opportunities Fund Boston, Massachusetts 02110 Tekla World Healthcare Fund Tel: (617) 772-8500 May 8, 2020 Via EDGAR Jeff Long U.

HQH / Tekla Healthcare Investors DEF 14A - - DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin

TEKLA WORLD HEALTHCARE FUND SCHEDULE OF INVESTMENTS DECEMBER 31, 2019

TEKLA WORLD HEALTHCARE FUND SCHEDULE OF INVESTMENTS DECEMBER 31, 2019 (Unaudited) PRINCIPAL AMOUNT VALUE CONVERTIBLE AND NON-CONVERTIBLE NOTES - 19.

THW / Tekla World Healthcare Fund NPORT-EX - -

TEKLA WORLD HEALTHCARE FUND SCHEDULE OF INVESTMENTS JUNE 30, 2019 (Unaudited) PRINCIPAL AMOUNT VALUE CONVERTIBLE AND NON-CONVERTIBLE NOTES - 20.

Notice of Change of Trustee dated June 13, 2019

Exhibit (a)(iv) TEKLA WORLD HEALTHCARE FUND Amendment to Declaration of Trust Notice of Change of Trustee WHEREAS Elizabeth G.

THW / Tekla World Healthcare Fund POS EX - - POST-EFFECTIVE AMENDMENT FILED SOLELY TO ADD EXHIBITS

As filed with the Securities and Exchange Commission on June 20 2019 Securities Act File No.

HQH / Tekla Healthcare Investors DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin

Notice of Change of Trustee dated December 13, 2018

Exhibit (a)(iii) TEKLA WORLD HEALTHCARE FUND Amendment to Declaration of Trust Notice of Change of Trustee WHEREAS Michael Bonney tendered his resignation as a Trustee of Tekla World Healthcare (the “Fund”) effective November 1, 2018, the Fund issues this notice in accordance with the terms of the Declaration of Trust of the Fund, dated March 5, 2015 and filed with the Secretary of State of the Commonwealth of Massachusetts on March 9, 2015, as amended; WHEREAS, at a meeting of the Trustees of Tekla World Healthcare Fund (“The Fund”) on December 13, 2018, the Trustees of the Fund appointed Dr.

Power of attorney dated December 13, 2018(5);

Exhibit (n)(ii) POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that Elizabeth G.

THW / Tekla World Healthcare Fund POST-EFFECTIVE AMENDMENT FILED SOLELY TO ADD EXHIBITS

As filed with the Securities and Exchange Commission on March 12, 2019 Securities Act File No.

EXHIBIT 1

Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of Tekla World Healthcare Fund; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading

Tekla World Healthcare Fund - N-Q

OMB APPROVAL OMB Number: 3235-0578 Expires: March 31, 2019 UNITED STATES Estimated average burden hours per response .

EXHIBIT 1

EX-99.CERT 2 a18-152594ex99dcert.htm EX-99.CERT Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of Tekla World Healthcare Fund; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under

THW / Tekla World Healthcare Fund N-Q (Quarterly Schedule of Portfolio Holdings)

N-Q 1 a18-152594nq.htm N-Q OMB APPROVAL OMB Number: 3235-0578 Expires: March 31, 2019 UNITED STATES Estimated average burden hours per response . . . . . . . . . . 10.5 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-23037 Tekla World Healthcare Fund (Exact

HQH / Tekla Healthcare Investors DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin

Assignment of the Support Services Agreement with Destra Capital Investments LLC to Destra Capital Advisors LLC dated April 2, 2018(4)

Exhibit (k)(vi) Destra Capital Management LLC One North Wacker Drive 48th Floor Chicago, Illinois 60606 April 2, 2018 VIA EMAIL Tekla Funds 100 Federal Street, 19th Floor Boston, MA 02110 Re: Assignment/Written Consent Dear Laura Woodward: Due to an internal business matter, the management at Destra Capital Management LLC (“DCM”), the parent company of Destra Capital Investments LLC (“Destra”), ha

THW / Tekla World Healthcare Fund POST-EFFECTIVE AMENDMENT FILED SOLELY TO ADD EXHIBITS

As filed with the Securities and Exchange Commission on April 18, 2018 Securities Act File No.

Notice of Change of Trustee dated December 20, 2017

Exhibit (a)(ii) TEKLA WORLD HEALTHCARE FUND Amendment to Declaration of Trust Notice of Change of Trustee WHEREAS, upon the death of Uwe E.

By-Laws of the Registrant, as amended

Exhibit (b) BY-LAWS OF TEKLA WORLD HEALTHCARE FUND Revised through April 4, 2018 ARTICLE I Definitions The terms “Commission,” “Custodian,” “Declaration,” “Distributor,” “Investment Adviser,” “Majority Shareholder Vote,” “1940 Act,” “Shareholder,” “Shares,” “Transfer Agent,” “Trust,” “Trust Property” and “Trustees” have the respective meanings given them in the Declaration of Trust of TeklaWorld Healthcare Fund dated March 5, 2015, as amended from time to time.

Power of Attorney dated April 9, 2018(4);

Exhibit (n)(ii) POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that Thomas M.

Tekla World Healthcare Fund - N-Q

OMB APPROVAL OMB Number: 3235-0578 Expires: March 31, 2019 UNITED STATES Estimated average burden hours per response .

EXHIBIT 1

EX-99.CERT 2 a18-24394ex99dcert.htm EX-99.CERT Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of Tekla World Healthcare Fund; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under w

EXHIBIT 1

Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of Tekla World Healthcare Fund; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading

Tekla World Healthcare Fund - N-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0578 Expires: March 31, 2019 Estimated average burden hours per response........10.5 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-23037 Tekla World Healthcare Fund (Exact name of registrant as specified in char

SUPPORT SERVICES AGREEMENT

Exhibit (k)(v) SUPPORT SERVICES AGREEMENT This Agreement is made as of January 1, 2016, by and among Tekla World Healthcare Fund, Tekla Healthcare Opportunities Fund, Tekla Healthcare Investors and Tekla Life Sciences Investors, Massachusetts business trusts (together, the ?Tekla Funds? or the ?Funds?), and Destra Capital Investments LLC, a Delaware limited liability company (?Destra?).

Tekla World Healthcare Fund POS EX

As filed with the Securities and Exchange Commission on June 19, 2017 Securities Act File No.

Tekla Healthcare Investors PRE 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin

EXHIBIT 1

EX-99.CERT 2 a17-19454ex99dcert.htm EX-99.CERT Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of Tekla World Healthcare Fund; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under w

Tekla World Healthcare Fund - N-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0578 Expires: March 31, 2019 Estimated average burden hours per response........10.5 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-23037 Tekla World Healthcare Fund (Exact name of registrant as specified in char

Tekla World Healthcare Fund N-Q (Quarterly Schedule of Portfolio Holdings)

N-Q 1 a16-157454nq.htm N-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0578 Expires: March 31, 2019 Estimated average burden hours per response........10.5 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-23037 Tekla World Healthcare Fund (Exact name of regi

EXHIBIT 1

EX-99.CERT 2 a16-157454ex99dcert.htm EX-99.CERT Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of Tekla World Healthcare Fund; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under

EXHIBIT 1

EX-99.CERT 2 a16-157454ex99dcert.htm EX-99.CERT Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of Tekla World Healthcare Fund; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under

Tekla World Healthcare Fund N-Q (Quarterly Schedule of Portfolio Holdings)

N-Q 1 a16-157454nq.htm N-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0578 Expires: March 31, 2019 Estimated average burden hours per response........10.5 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-23037 Tekla World Healthcare Fund (Exact name of regi

Tekla World Healthcare Fund DEF 14A

DEF 14A 1 a16-53331def14a.htm DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as

Tekla Healthcare Investors ESP

One International Place, 40th Floor 100 Oliver Street Boston, MA 02110-2605 +1 617 728 7100 Main +1 617 426 6567 Fax www.

Tekla World Healthcare Fund PRE 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: x Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Defin

EXHIBIT 1

EX-99.CERT 2 a16-17094ex99dcert.htm EX-99.CERT Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of Tekla World Healthcare Fund; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under w

Tekla World Healthcare Fund N-Q (Quarterly Schedule of Portfolio Holdings)

N-Q 1 a16-17094nq.htm N-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0578 Expires: January 31, 2016 Estimated average burden hours per response........10.5 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-23037 Tekla World Healthcare Fund (Exact name of reg

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 19, 2015 TEKLA WORLD HEALTHCARE FUND (Exact name of Registrant as specified in its charter) Massachusetts (State or other jurisdiction of incorporation) 811-23037 47-3910842 (

TEKLA WORLD HEALTHCARE FUND INTRODUCES FACT CARD

Exhibit 99.1. FOR IMMEDIATE RELEASE TEKLA WORLD HEALTHCARE FUND INTRODUCES FACT CARD BOSTON, MA, October 19, 2015 — Tekla World Healthcare Fund (NYSE: THW) is pleased to introduce its first fact card. The fact card, which summarizes Fund information which may include quarterly data regarding the Fund including performance, portfolio holdings, geographic and sector information, will be available at

EXHIBIT 1

Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of Tekla World Healthcare Fund; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading

Tekla World Healthcare Fund N-Q (Quarterly Schedule of Portfolio Holdings)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0578 Expires: January 31, 2016 Estimated average burden hours per response........10.5 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-23037 Tekla World Healthcare Fund (Exact name of registrant as specified in ch

Tekla World Healthcare Fund ESP

TEKLA WORLD HEALTHCARE FUND 100 Federal Street, 19th Floor Boston, MA 02110 VIA EDGAR June 23, 2015 Karen Rossotto Senior Counsel Division of Investment Management Securities and Exchange Commission 100 F Street, N.

Tekla World Healthcare Fund 8-A12B

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(B) OR (G) OF THE SECURITIES EXCHANGE ACT OF 1934 TEKLA WORLD HEALTHCARE FUND (Exact name of Registrant as specified in Charter) Massachusetts 47-3910842 (State of incorporation or organization) (IRS Employer Identification No.) 100 Federal Street

Tekla World Healthcare Fund ESP

teklaworldhcfcorrpmay2015.htm [DECHERT LETTERHEAD] May 15, 2015 VIA EDGAR Karen Rossotto Senior Counsel Division of Investment Management Securities and Exchange Commission Washington, D.C. 20549 Re: Tekla World Healthcare Fund File Nos. 333-202638; 811-23037 Dear Ms. Rossotto: We are writing to provide for your review a draft fee table, expense example and statement of assets and liabilities. The

Tekla World Healthcare Fund ESP

twhfcorr042915.htm [DECHERT LLP LETTERHEAD] May 6, 2015 Karen Rossotto Senior Counsel Division of Investment Management Securities and Exchange Commission Washington, D.C. 20549 Re: Tekla World Healthcare Fund File Nos. 333-202638; 811-23037 Dear Ms. Rossotto: We are writing in response to comments provided on April 9, 2015 with respect to a registration statement (the ?Registration Statement?) fi

Tekla World Healthcare Fund FORM N-8A

teklan8a030515.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM N-8A NOTIFICATION OF REGISTRATION FILED PURSUANT TO SECTION 8(a) OF THE INVESTMENT COMPANY ACT OF 1940 The undersigned investment company hereby notifies the Securities and Exchange Commission that it registers under and pursuant to the provisions of Section 8(a) of the Investment Company Act of 1940, a